Norihisa Nishida Selected Research

kaempferol

6/2007

Potent anti-obese principle from Rosa canina: structural requirements and mode of action of trans-tiliroside.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norihisa Nishida Research Topics

Disease

4	Body Weight (Weight, Body) 01/2015 - 07/2002
3	Obesity 02/2023 - 06/2013
1	Mental Fatigue 10/2020
1	Fatigue 10/2020
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 07/2019
1	Diabetes Complications 09/2015
1	Arteriosclerosis 09/2015
1	Hyperinsulinism (Hyperinsulinemia) 03/2012
1	Neoplasms (Cancer) 01/2012
1	Stomatitis 01/2012

Drug/Important Bio-Agent (IBA)

3	paramylonIBA 02/2023 - 07/2019
3	tilirosideIBA 06/2013 - 06/2007
2	PowdersIBA 02/2023 - 07/2019
1	AntioxidantsIBA 10/2020
1	GlucansIBA 07/2019
1	Dietary Fiber FDA Link 07/2019
1	Advanced Glycation End ProductsIBA 09/2015
1	TabletsIBA 01/2015
1	Fatty Acids (Saturated Fatty Acids)IBA 06/2013
1	Starch (Cornstarch)IBA 03/2012
1	Allopurinol (Remid)FDA LinkGeneric 01/2012
1	Dosage Forms (Dosage Form)IBA 01/2012
1	Blood Glucose (Blood Sugar)IBA 06/2007
1	AcetoneIBA 06/2007
1	Glucose (Dextrose)FDA LinkGeneric 06/2007
1	p-coumaric acidIBA 06/2007
1	astragalinIBA 06/2007
1	kaempferolIBA 06/2007
1	salvinIBA 04/2004

Therapy/Procedure

1	Radiotherapy 01/2012
1	Drug Therapy (Chemotherapy) 01/2012
1	Oral Administration 07/2002